News

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

FDA Approves First Non-Antipsychotic for Dementia Agitation

FDA · agitation associated with dementia due to Alzheimer's disease · 6 min

Edwards Lifesciences RESILIA Tissue Shows 10-Year Durability in Pivotal Aortic Valve Trial

2 min

BioMarin VOXZOGO Shows Long-Term Benefits for Achondroplasia in New Clinical Data at PES 2026

2 min

FDA Approves Incyte's Jakafi XR Extended-Release Tablets for Myelofibrosis, Polycythemia Vera Treatment

Hematology/Oncology · 3 min

Plozasiran TGA Approval: REDEMPLO® Now Available in Australia for FCS

TGA · Familial Chylomicronemia Syndrome (FCS) · 6 min

Neurocrine Biosciences CRENESSITY Shows Sustained Benefits in Two-Year Pediatric CAH Study

2 min

Cairn Surgical's Breast Cancer Locator System Meets Primary Endpoint in Pivotal Trial, Reduces Positive Margin Rates

2 min

Restore Vision Reports Positive Safety Data for RV-001 Gene Therapy in Retinitis Pigmentosa Trial

2 min

ARCHIMED Acquires Esperion Therapeutics in Strategic Cardiometabolic Deal

cardiometabolic and rare/orphan diseases · 3 min

Oculis to Present DME Research and Pipeline Updates at ARVO 2026 Annual Meeting

2 min

Rhythm Pharmaceuticals' IMCIVREE Receives European Commission Approval for Acquired Hypothalamic Obesity

Rare neuroendocrine diseases / Obesity · 3 min